Strategies to counteract or prevent emerging drug resistance are crucial for the design of
next-generation antimalarials. In the past, resistant parasites were generally identified …

Malaria contributes to the most widespread infectious diseases worldwide. Even though
current drugs are commercially available, the ever-increasing drug resistance problem by …

Antimalarial drugs have played a mainstream role in controlling the spread of malaria
through the treatment of patients infected with the plasmodial parasites and controlling its …

Proteomics of membrane proteins is essential for the understanding of cellular function.
However, mass spectrometric analysis of membrane proteomes has been less successful …

Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei are protozoan parasites that
cause a spectrum of fatal human diseases around the world. Recent completion of the …

The diseases caused by protozoan parasite are responsible for considerable mortality and
morbidity, affecting more than 500 million of people in the world. The epidemiological control …

Global efforts to eradicate malaria are threatened by multiple factors, particularly the
emergence of anti-malarial drug resistant strains of Plasmodium falciparum. Heat shock …

We have adopted a proteomic strategy to investigate the actions of the two active
components of the new antimalarial CoArtem, artemether and lumefantrine, following …

The human malaria parasite, Plasmodium falciparum, is a unicellular protozoan responsible
for over half a million deaths annually. With a complex life cycle alternating between human …

Visceral leishmaniasis (VL) is a major fatal disease prevalent in North-East India, caused by
a protozoan parasite Leishmania donovani. The parasite multiplies and thrives inside …